DE2311099A1 - Psychopharmakologisch aktive peptide und peptidderivate - Google Patents
Psychopharmakologisch aktive peptide und peptidderivateInfo
- Publication number
- DE2311099A1 DE2311099A1 DE19732311099 DE2311099A DE2311099A1 DE 2311099 A1 DE2311099 A1 DE 2311099A1 DE 19732311099 DE19732311099 DE 19732311099 DE 2311099 A DE2311099 A DE 2311099A DE 2311099 A1 DE2311099 A1 DE 2311099A1
- Authority
- DE
- Germany
- Prior art keywords
- phe
- met
- group
- peptide
- glu
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/665—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans derived from pro-opiomelanocortin, pro-enkephalin or pro-dynorphin
- C07K14/695—Corticotropin [ACTH]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Toxicology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
NL7203042A NL7203042A (sv) | 1972-03-08 | 1972-03-08 |
Publications (1)
Publication Number | Publication Date |
---|---|
DE2311099A1 true DE2311099A1 (de) | 1973-09-13 |
Family
ID=19815540
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE19732311099 Pending DE2311099A1 (de) | 1972-03-08 | 1973-03-06 | Psychopharmakologisch aktive peptide und peptidderivate |
Country Status (12)
Country | Link |
---|---|
JP (1) | JPS48103575A (sv) |
AU (1) | AU471618B2 (sv) |
BE (1) | BE796478A (sv) |
CA (1) | CA1025439A (sv) |
CH (1) | CH584681A5 (sv) |
DE (1) | DE2311099A1 (sv) |
FR (1) | FR2181803B1 (sv) |
GB (1) | GB1425099A (sv) |
HU (1) | HU169157B (sv) |
NL (1) | NL7203042A (sv) |
SE (1) | SE406761B (sv) |
ZA (1) | ZA731207B (sv) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0162079A1 (en) * | 1983-11-07 | 1985-11-27 | The Board Of Trustees Of The Leland Stanford Junior University | Use of arg-phe-amide derivatives |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2710617T3 (es) | 2010-04-21 | 2019-04-26 | Signature Therapeutics Inc | Composiciones que comprenden profármacos de anfetamina escindibles enzimáticamente e inhibidores de los mismos |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1301738A (sv) * | 1969-07-09 | 1973-01-04 |
-
1972
- 1972-03-08 NL NL7203042A patent/NL7203042A/xx not_active Application Discontinuation
-
1973
- 1973-02-20 ZA ZA731207A patent/ZA731207B/xx unknown
- 1973-02-22 AU AU52511/73A patent/AU471618B2/en not_active Expired
- 1973-03-01 GB GB1006273A patent/GB1425099A/en not_active Expired
- 1973-03-05 HU HUAO352A patent/HU169157B/hu unknown
- 1973-03-06 DE DE19732311099 patent/DE2311099A1/de active Pending
- 1973-03-06 CH CH328873A patent/CH584681A5/xx not_active IP Right Cessation
- 1973-03-07 JP JP48026885A patent/JPS48103575A/ja active Pending
- 1973-03-07 SE SE7303180A patent/SE406761B/sv unknown
- 1973-03-07 CA CA165,427A patent/CA1025439A/en not_active Expired
- 1973-03-08 FR FR7308346A patent/FR2181803B1/fr not_active Expired
- 1973-03-08 BE BE128545A patent/BE796478A/xx unknown
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0162079A1 (en) * | 1983-11-07 | 1985-11-27 | The Board Of Trustees Of The Leland Stanford Junior University | Use of arg-phe-amide derivatives |
EP0162079A4 (en) * | 1983-11-07 | 1989-01-19 | Univ Leland Stanford Junior | USE OF ARG-PHE-AMIDE DERIVATIVES. |
Also Published As
Publication number | Publication date |
---|---|
NL7203042A (sv) | 1973-09-11 |
SE406761B (sv) | 1979-02-26 |
CH584681A5 (sv) | 1977-02-15 |
AU471618B2 (en) | 1976-04-29 |
ZA731207B (en) | 1973-11-28 |
AU5251173A (en) | 1974-08-22 |
JPS48103575A (sv) | 1973-12-25 |
CA1025439A (en) | 1978-01-31 |
HU169157B (sv) | 1976-10-28 |
BE796478A (fr) | 1973-09-10 |
FR2181803B1 (sv) | 1976-09-03 |
GB1425099A (en) | 1976-02-18 |
FR2181803A1 (sv) | 1973-12-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CH629475A5 (de) | Verfahren zur herstellung von polypeptiden. | |
DD217807A5 (de) | Verfahren zur herstellung neuer substituierter tetrapeptide | |
DE2649146A1 (de) | Nonapeptide | |
DE2315826A1 (de) | Psychopharmakologisch aktive peptide und peptidderivate | |
DE2308362A1 (de) | Psychopharmakologisch aktive peptide und peptidderivate | |
DE2730549A1 (de) | Peptidderivate und deren herstellung | |
DE2544348A1 (de) | L-leucin-13-motilin, verfahren zu dessen herstellung und dasselbe enthaltendes mittel | |
CH636598A5 (de) | Verfahren zur herstellung neuer psychopharmakologisch aktiver peptide. | |
DE1493878C3 (de) | Acylierte Peptidderivate, Verfahren zur Herstellung derselben und pharmazeutische Präparate, welche solche acylierte Peptidderivate enthalten | |
DE2335826C2 (de) | Peptide und deren Derivate sowie diese Verbindungen enthaltende Arzneimittel | |
CH424797A (de) | Verfahren zur Herstellung neuer Oktapeptide mit vasopressorischer Wirksamkeit | |
DE2731282A1 (de) | Psychopharmakologisch wirksame peptide und peptidderivate und verfahren zu deren herstellung | |
DE2326033C2 (de) | Peptide und deren Derivate sowie diese Verbindungen enthaltende Arzneimittel mit psychopharmakologischer Wirkung | |
DE1518133B1 (de) | Verfahren zur Herstellung eines neuen hypotensiv wirkenden Hendekapeptids | |
DE2311099A1 (de) | Psychopharmakologisch aktive peptide und peptidderivate | |
DE2633976A1 (de) | Tripeptidderivate, verfahren zu ihrer herstellung sowie diese enthaltende arzneimittel | |
DE1248059B (de) | Verfahren zur Herstellung bradykininwirksamer Undeca- und Dodecapeptide | |
CH658661A5 (de) | Peptidverbindungen. | |
DE2305727C2 (de) | Pentapeptide und deren Derivate sowie diese Verbindungen enthaltende Arzneimittel | |
DE2649114A1 (de) | Octapeptide | |
DE3236484A1 (de) | Tripeptide, verfahren zur herstellung derselben und diese enthaltende arzneimittel | |
DD296084A5 (de) | Verfahren zur herstellung von humanen spleninderivaten | |
DE2114300C3 (de) | Octadekapeptide und Arzneipräparate | |
DE2559928C2 (de) | N-Aroyl-L-phenylalanyl-L-tyrosine, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel | |
CH499497A (de) | Verfahren zur Herstellung neuer Polypeptide |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
OHA | Expiration of time for request for examination |